HomeBIO • NYSE
add
Bio-Rad Laboratories, Inc. Class A Common Stock
Previous close
$325.58
Day range
$321.62 - $334.71
Year range
$262.12 - $387.99
Market cap
9.37B USD
Avg Volume
202.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 649.73M | 2.79% |
Operating expense | 291.34M | 19.14% |
Net income | 653.17M | 514.71% |
Net profit margin | 100.53 | 498.04% |
Earnings per share | 2.01 | -13.73% |
EBITDA | 103.47M | -19.45% |
Effective tax rate | 24.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.62B | -7.76% |
Total assets | 10.60B | -10.86% |
Total liabilities | 3.12B | -10.46% |
Total equity | 7.49B | — |
Shares outstanding | 28.00M | — |
Price to book | 1.22 | — |
Return on assets | 1.59% | — |
Return on capital | 1.89% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 653.17M | 514.71% |
Cash from operations | 163.56M | 67.39% |
Cash from investing | -55.64M | -485.64% |
Cash from financing | -95.99M | -260.88% |
Net change in cash | 4.47M | -93.41% |
Free cash flow | 23.87M | -46.32% |
About
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
Founded
1952
Headquarters
Website
Employees
8,030